Identification of Distinct Psychosis Biotypes Using Brain-Based Biomarkers

Abstract

These data illustrate how multiple pathways may lead to clinically similar psychosis manifestations, and they provide explanations for the marked heterogeneity observed across laboratories on the same biomarker variables when DSM diagnoses are used as the gold standard.